Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Osaterone enhances bone formation in ovariectomized rats

May 12, 1997

Effects of L-692429 in obese and nonobese young men

May 12, 1997

Procter & Gamble and Hoechst Marion Roussel to comarket Actonel

May 12, 1997

Prodrugs of calcitriol disclosed by Wisconsin Alumni Research Foundation

May 12, 1997

Selective beta3-agonists from Lilly

May 12, 1997

Lilly discloses selective beta3-agonists

May 9, 1997

Smith & Nephew to evaluate DynaGen's Orthodyn

May 9, 1997

Baxter files European marketing application for HemAssist

May 8, 1997

CSID enzyme replacement therapy submitted for approval

May 8, 1997

FDA decision on generic Premarin

May 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...